Literature DB >> 8859901

Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA.

T Nishiki1, Y Tokuyama, Y Kamata, Y Nemoto, A Yoshida, M Sekiguchi, M Takahashi, S Kozaki.   

Abstract

We have previously identified synaptotagmin, a synaptic vesicle membrane protein from rat brain, as a binding protein for Clostridium botulinum type B neurotoxin. In this report, rat synaptotagmin II was expressed by transfection in Chinese hamster ovary cells and interaction with the neurotoxin was studied. In stable transfectants, the NH(2)-terminal region of synaptotagmin was exposed to the extracellular medium. Synaptotagmin-expressing cells were shown to possess an extremely low binding activity for the radiodinated toxin. However, toxin-binding was markedly increased to cells which had been treated with gangliosides G T1b or G D1a. In synapses, the intravesicular NH(2)-terminus of synaptotagmin becomes exposed at the cell surface after following exocytosis. These findings suggest that the NH(2)-terminal domain of synaptotagmin II forms the binding site for type B neurotoxin by associating with specific gangliosides in presynaptic plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8859901     DOI: 10.1016/0304-3940(96)12557-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

Review 1.  Botulinum neurotoxin - from laboratory to bedside.

Authors:  K A Foster; H Bigalke; K R Aoki
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

2.  Characterization of Clostridial botulinum neurotoxin channels in neuroblastoma cells.

Authors:  A Fisher; M Montal
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

3.  Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes.

Authors:  Audrey Fischer; Mauricio Montal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

4.  Inhibition of botulinum neurotoxin a toxic action in vivo by synthetic synaptosome- and blocking antibody-binding regions.

Authors:  M Zouhair Atassi; Behzod Z Dolimbek; Lance E Steward; K Roger Aoki
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

Review 5.  Unique ganglioside binding by botulinum neurotoxins C and D-SA.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

Review 6.  Interaction of botulinum toxin with the epithelial barrier.

Authors:  Yukako Fujinaga
Journal:  J Biomed Biotechnol       Date:  2010-02-14

7.  Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.

Authors:  M Zouhair Atassi; Midori Taruishi; Masooma Naqvi; Lance E Steward; K Roger Aoki
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

8.  Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.

Authors:  Zhuji Fu; Chen Chen; Joseph T Barbieri; Jung-Ja P Kim; Michael R Baldwin
Journal:  Biochemistry       Date:  2009-06-23       Impact factor: 3.162

Review 9.  Association of botulinum neurotoxins with synaptic vesicle protein complexes.

Authors:  Michael R Baldwin; Joseph T Barbieri
Journal:  Toxicon       Date:  2009-04-09       Impact factor: 3.033

10.  Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.

Authors:  Ronnie Per-Arne Berntsson; Lisheng Peng; Linda Marie Svensson; Min Dong; Pål Stenmark
Journal:  Structure       Date:  2013-08-08       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.